Junzhong Lin

2.7k total citations · 3 hit papers
64 papers, 1.7k citations indexed

About

Junzhong Lin is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Junzhong Lin has authored 64 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 22 papers in Surgery and 14 papers in Molecular Biology. Recurrent topics in Junzhong Lin's work include Colorectal Cancer Surgical Treatments (20 papers), Colorectal Cancer Treatments and Studies (18 papers) and Colorectal and Anal Carcinomas (13 papers). Junzhong Lin is often cited by papers focused on Colorectal Cancer Surgical Treatments (20 papers), Colorectal Cancer Treatments and Studies (18 papers) and Colorectal and Anal Carcinomas (13 papers). Junzhong Lin collaborates with scholars based in China, United States and Macao. Junzhong Lin's co-authors include Zhizhong Pan, Jianhong Peng, Rui‐Hua Xu, Zhenhai Lu, Miao‐Zhen Qiu, Huai‐Qiang Ju, Xiaojun Wu, Zexian Liu, Kun Liao and Qingjian Ou and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Junzhong Lin

60 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer

2023 240 citations Weihao Li, Chi Zhou et al. Autophagy profile →
Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis

2022 226 citations Jin‐Fei Lin, Kai Yu et al. profile →
Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study

2023 77 citations Gong Chen, Ying Jin et al. The Lancet. Gastroenterology & hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Junzhong Lin China	19	846	629	572	311	294	64	1.7k
Federica Papaccio Italy	21	1.0k 1.2×	909 1.4×	594 1.0×	293 0.9×	164 0.6×	42	2.0k
Yong Xu China	26	1.1k 1.3×	461 0.7×	631 1.1×	404 1.3×	226 0.8×	83	2.1k
Omar M. Rashid United States	25	786 0.9×	738 1.2×	450 0.8×	415 1.3×	241 0.8×	68	1.7k
Liangping Xia China	18	956 1.1×	660 1.0×	692 1.2×	232 0.7×	202 0.7×	75	1.9k
Niranjan Awasthi United States	25	889 1.1×	703 1.1×	338 0.6×	294 0.9×	211 0.7×	65	1.9k
Yin‐Hsun Feng Taiwan	20	732 0.9×	475 0.8×	476 0.8×	195 0.6×	198 0.7×	69	1.5k
Dayong Zheng China	19	835 1.0×	476 0.8×	517 0.9×	331 1.1×	149 0.5×	62	1.5k
Hao‐Xiang Wu China	22	520 0.6×	596 0.9×	393 0.7×	289 0.9×	141 0.5×	38	1.3k
JiHoon Kang South Korea	21	642 0.8×	493 0.8×	476 0.8×	275 0.9×	133 0.5×	63	1.4k
Wence Zhou China	18	584 0.7×	574 0.9×	452 0.8×	405 1.3×	398 1.4×	90	1.7k

Countries citing papers authored by Junzhong Lin

Since Specialization

Citations

This map shows the geographic impact of Junzhong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junzhong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junzhong Lin more than expected).

Fields of papers citing papers by Junzhong Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junzhong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junzhong Lin. The network helps show where Junzhong Lin may publish in the future.

Co-authorship network of co-authors of Junzhong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Junzhong Lin. A scholar is included among the top collaborators of Junzhong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junzhong Lin. Junzhong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Weihao, Jiayu Wang, Xiaojun Wu, et al.. (2024). MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases. Clinical & Translational Oncology. 27(4). 1681–1694. 1 indexed citations

Peng, Jianhong, Weihao Li, Peirong Ding, et al.. (2024). Comparison of robotic and laparoscopic surgery for sigmoid colon and rectal cancer: a single-center retrospective study on surgical outcomes and long-term survival. Journal of Robotic Surgery. 18(1). 299–299.

Li, Rui, Xuefei Liu, Xudong Huang, et al.. (2023). Single-cell transcriptomic analysis deciphers heterogenous cancer stem-like cells in colorectal cancer and their organ-specific metastasis. Gut. 73(3). 470–484. 45 indexed citations

Li, Weihao, Chi Zhou, Long Yu, et al.. (2023). Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer. Autophagy. 20(1). 114–130. 240 indexed citations breakdown →

Chen, Gong, Ying Jin, Wen‐Long Guan, et al.. (2023). Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study. The Lancet. Gastroenterology & hepatology. 8(5). 422–431. 77 indexed citations breakdown →

Zeng, Kaixuan, Jianhong Peng, Yue Xing, et al.. (2023). A positive feedback circuit driven by m6A-modified circular RNA facilitates colorectal cancer liver metastasis. Molecular Cancer. 22(1). 202–202. 37 indexed citations

Li, Weihao, Jian Zhou, Hui Sun, et al.. (2023). Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment. European Journal of Radiology. 165. 110950–110950. 1 indexed citations

Xu, Yanbo, Weihao Li, Weili Zhang, et al.. (2022). The Pathologic Complete Response Ratio of Liver Metastases Represents a Valuable Prognostic Indicator. Pathology & Oncology Research. 28. 1610663–1610663. 3 indexed citations

Peng, Jianhong, Weihao Li, Wenhua Fan, et al.. (2021). Prognostic value of a novel biomarker combining DNA ploidy and tumor burden score for initially resectable liver metastases from patients with colorectal cancer. Cancer Cell International. 21(1). 554–554. 6 indexed citations

10.

Ruan, Dan‐Yun, Ting Li, Yingnan Wang, et al.. (2021). FTO downregulation mediated by hypoxia facilitates colorectal cancer metastasis. Oncogene. 40(33). 5168–5181. 116 indexed citations

11.

Peng, Jianhong, Weihao Li, Jinghua Tang, et al.. (2021). Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China. Frontiers in Surgery. 8. 696026–696026. 2 indexed citations

12.

Xiao, Binyi, Jianhong Peng, Yongchun Wang, et al.. (2020). Prognostic value of tumor infiltrating lymphocytes combined with PD-L1 expression for patients with solitary colorectal cancer liver metastasis. Annals of Translational Medicine. 8(19). 1221–1221. 14 indexed citations

13.

Peng, Jianhong, Weihao Li, Wenhua Fan, et al.. (2020). Feasibility Study of a Modified XELOX Adjuvant Chemotherapy for High-Recurrence Risk Patients With Operated Stage III Colon Cancer. Frontiers in Pharmacology. 11. 583091–583091. 1 indexed citations

14.

Deng, Yuxiang, Jianhong Peng, Yujie Zhao, et al.. (2018). Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection. Cancer Management and Research. Volume 10. 2083–2094. 11 indexed citations

15.

Sui, Qiaoqi, Junzhong Lin, Jianhong Peng, et al.. (2017). Local surgical excision versus endoscopic resection for rectal carcinoid: A meta-analysis.. Journal of Cancer. 8(19). 3969–3974. 4 indexed citations

16.

Fang, Cheng, Wei Wang, Xingyu Feng, et al.. (2017). Nomogram individually predicts the overall survival of patients with gastroenteropancreatic neuroendocrine neoplasms. British Journal of Cancer. 117(10). 1544–1550. 83 indexed citations

17.

Xiao, Binyi, Jianhong Peng, Rongxin Zhang, et al.. (2017). Density of CD8+ lymphocytes in biopsy samples combined with the circulating lymphocyte ratio predicts pathologic complete response to chemoradiotherapy for rectal cancer. Cancer Management and Research. Volume 9. 701–708. 13 indexed citations

18.

Lin, Junzhong, Jianhong Peng, Aiham Qdaisat, et al.. (2016). Severe weight loss during preoperative chemoradiotherapy compromises survival outcome for patients with locally advanced rectal cancer. Journal of Cancer Research and Clinical Oncology. 142(12). 2551–2560. 32 indexed citations

19.

Liu, Guochen, Xu Zhang, Enzehua Xie, et al.. (2015). The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer. Medicine. 94(47). e2074–e2074. 7 indexed citations

20.

Gao, Yuanhong, X. Zhang, Xin An, et al.. (2014). Oxaliplatin and capecitabine concomitant with neoadjuvant radiotherapy and extended to the resting period in high risk locally advanced rectal cancer. Strahlentherapie und Onkologie. 190(2). 158–164. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact